Log In
BCIQ
Print this Print this
 

ORE1001 (GL1001)

  Manage Alerts
Collapse Summary General Information
Company Ore Holdings Inc.
DescriptionSmall molecule inhibitor of the angiotensin-converting enzyme 2 (ACE2)
Molecular Target Angiotensin-converting enzyme 2 (ACE2)
Mechanism of ActionAngiotensin-converting enzyme (ACE) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I/II
Standard IndicationInflammatory bowel disease (IBD)
Indication DetailsTreat inflammatory bowel disease (IBD); Treat ulcerative colitis (UC)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today